The Breakthrough Therapy designation for olomorasib is based on data from the Phase 1/2 LOXO-RAS-20001 trial and Phase 3 SUNRAY-01 trial Updated efficacy and safety data for olomorasib will be presented at the IASLC 2025 World Conference on Lung Cancer INDIANAPOLIS, Sept. 4, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasib, in combination with anti-PD-1 therapy KEYTRUDA (pembroli ...

Joby Aviation ( JOBY ) is shifting from conceptual discussions to execution-oriented champion of urban air mobility. With 70% certification progress, military deals on the books, and acquisition of Blade to accelerate commercialization, Joby has first-mover advantages thatHi, I'm Yiannis. Spotting winners before they break out is what I do best.Experience: Previously worked at Deloitte and KPMG in external/internal auditing and consulting. Education: Chartered Certified Accountant, Fellow Member of ACCA Glo ...

SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Snap Inc. (NYSE: SNAP) securities between April 29, 2025 and August 5, 2025, all dates inclusive (the “Class Period”), have until October 20, 2025 to seek appointment as lead plaintiff of the Snap class action lawsuit. Captioned Abdul-Hameed v. Snap Inc., No. 25-cv-07844 (C.D. Cal.), the Snap class action lawsuit charges Snap as well as certain of Snap’s top executives with violations of ...

With less uncertainty surrounding interest rates now but the potential for further weakening as a result of how tariffs will impact consumers in the coming months, certain sectors remain at higher risk as a result. OneContributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own d ...

Drilling Continues to Highlight the Potential for Resource Growth at Enchi, Intersects High-Grade Gold Mineralization at the Pre-Resource Stage Kojina Hill Gold TargetVANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% owned Enchi Gold Project ("Enchi" or the "Project") in Ghana. Shallow Reverse Circulation ( ...

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: Credit: Unsplash/CC0 Public Domain Since the dawn of the new millennium, there have been at most several thousand startup tech companies across the U.S. that have achieved unicorn status—crossing the $1 billion valuation. Eric Lefkofsky, 55, the Chicago-based serial entrepreneur best known for co-founding online daily deals si ...

How something works gives us a good guide to what that thing might be useful for. Hammers are heavy and are useful for hitting things with - there, proof.Tim Worstall is a wholesaler of rare earth metals and one of the global experts in the metal scandium. He is also a Fellow at the Adam Smith Inst in London and an writer for a number of media outlets, including The Times (London), Telegraph, The Register and even, very occasionally indeed, for the WSJ. This account is linked with that of Mohamad Machine-Ch ...

ALK (ALKB:DC / OMX: ALK B) today announced the decision to elevate its key commercial regions into the Executive Leadership Team (ELT) to further strengthen the execution of ALK’s strategy, Allergy+. Effective as of 1 October 2025, ALK’s two key commercial regions, Europe and North America, will be directly represented in the ELT. Dr. Flora Beiche-Scholz – who currently holds the position as Senior Vice President for region Europe – will join the ELT in a new position as Executive Vice President (EVP) and ...

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in September: September 8-10: H.C. Wainwright 27th Annual Global Investment Conference. Jason Tardio, President and Chief Operating Officer of Immunic, will present a company overview. The on-demand presen ...

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American" or the "Company") and MAG Silver Corp. (NYSE American: MAG) (TSX: MAG) ("MAG") are pleased to announce that Pan American has completed its previously announced acquisition of all of the issued and outstanding common shares of MAG ("MAG Shares") pursuant to a plan of arrangement (the "Transaction"). The Transaction adds a 44% joint venture interest in the large-scale, high-grade ...